CHYM trades 70.5% below Wall Street's consensus target of $30.00.
Last 12 months price action with 12-month analyst target path
The base valuation assumes CHYM achieves its forward estimates and maintains a stable P/E multiple of 57.9x. This scenario reflects the blended consensus of 9 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of June 23, 2026, Chime Financial, Inc. Class A Common Stock (CHYM) has a Wall Street consensus price target of $30.00, based on estimates from 9 covering analysts. With the stock currently trading at $16.92, this represents a potential upside of +70.5%. The company has a market capitalization of $6.78B.
Analyst price targets range from a low of $29.00 to a high of $31.00, representing a 7% spread in expectations. The median target of $30.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 8 analysts rating the stock as a Buy or Strong Buy,1 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, CHYM trades at a trailing P/E of -6.4x and forward P/E of 57.9x. Analysts expect EPS to grow +112.6% over the next year.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
SOFISoFi Technologies, Inc. | $21.8B | $17.10 | $21.40 | +19.5% | Hold | 30.0x | 27 |
DAVEDave Inc. | $4.2B | $309.72 | $325.80 | +3.6% | Buy | 19.7x | 11 |
MQMarqeta, Inc. | $1.6B | $3.76 | $4.75 | +22.4% | Hold | 100.0x | 22 |
AFRMAffirm Holdings, Inc. | $24.1B | $72.20 | $81.93 | +10.8% | Buy | 59.1x | 33 |
OPFIOppFi Inc. | $721M | $8.36 | $11.00 | +30.5% | Buy | 4.7x | 6 |
PYPLPayPal Holdings, Inc. | $37.3B | $42.34 | $50.45 | +18.7% | Hold | 8.0x | 70 |
GPNGlobal Payments Inc. | $15.4B | $65.09 | $87.50 | +30.8% | Buy | 4.8x | 62 |
NRDSNerdWallet, Inc. | $603M | $8.28 | $13.33 | +59.1% | Buy | 9.2x | 6 |
LMNDLemonade, Inc. | $4.4B | $57.51 | $71.00 | +20.7% | Buy | — | 15 |
UPSTUpstart Holdings, Inc. | $3.0B | $31.32 | $37.25 | +14.9% | Buy | 14.1x | 22 |
Quick answers to the most common questions about buying CHYM stock.
The consensus Wall Street price target for CHYM is $30, representing 70.5% upside from the current price of $16.92. With 9 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
CHYM has a consensus rating of "Buy" based on 9 Wall Street analysts. The rating breakdown is predominantly bullish, with 8 Buy/Strong Buy ratings. The consensus 12-month price target of $30 implies 70.5% upside from current levels.
At a forward P/E of 57.9329x, CHYM trades at a premium valuation. The consensus price target of $30 (70.5% upside) suggests analysts still see growth justifying the multiple.
The most bullish Wall Street analyst has a price target of $31 for CHYM, while the most conservative target is $29. The consensus of $30 represents the median expectation. These targets typically reflect 12-month expectations.
CHYM is moderately covered, with 9 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 8 have Buy ratings, 1 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month CHYM stock forecast based on 9 Wall Street analysts shows a consensus price target of $30, with estimates ranging from $29 (bear case) to $31 (bull case). The median consensus rating is "Buy".
CHYM trades at a forward P/E ratio of 57.9x based on next-twelve-months earnings estimates. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on CHYM, with a "Buy" consensus rating and $30 price target (70.5% upside). 8 of 9 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
CHYM analyst price targets range from $29 to $31, a 7% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $30 consensus represents the middle ground.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.